Published in Psychiatr Genet on January 01, 1994
Glutamatergic abnormalities of the thalamus in schizophrenia: a systematic review. J Neural Transm (Vienna) (2008) 0.93
A protein interaction based model for schizophrenia study. BMC Bioinformatics (2008) 0.79
Variable number of tandem repeat (VNTR) markers for human gene mapping. Science (1987) 25.71
A closely linked genetic marker for cystic fibrosis. Nature (1985) 7.85
Linkage of a neurophysiological deficit in schizophrenia to a chromosome 15 locus. Proc Natl Acad Sci U S A (1997) 4.89
Growth of Campylobacter pylori in liquid media. J Clin Microbiol (1987) 4.31
Cloning of infectious adeno-associated virus genomes in bacterial plasmids. Gene (1983) 4.15
Regulation of sexual differentiation in D. melanogaster via alternative splicing of RNA from the transformer gene. Cell (1987) 3.86
Genome-wide association study of bipolar disorder in European American and African American individuals. Mol Psychiatry (2009) 3.64
A primary genetic linkage map for human chromosome 12. Genomics (1987) 2.72
Neurophysiological evidence for a defect in neuronal mechanisms involved in sensory gating in schizophrenia. Biol Psychiatry (1982) 2.60
Singleton deletions throughout the genome increase risk of bipolar disorder. Mol Psychiatry (2008) 2.50
The yeast ARD1 gene product is required for repression of cryptic mating-type information at the HML locus. Mol Cell Biol (1987) 2.30
An international two-stage genome-wide search for schizophrenia susceptibility genes. Nat Genet (1995) 2.26
Macrocephaly in children and adults with autism. J Am Acad Child Adolesc Psychiatry (1997) 2.26
Intravascular extraction of problematic or infected permanent pacemaker leads: 1994-1996. U.S. Extraction Database, MED Institute. Pacing Clin Electrophysiol (1999) 2.24
Evidence of linkage disequilibrium between schizophrenia and the SCa1 CAG repeat on chromosome 6p23. Am J Hum Genet (1996) 2.19
Normalization of auditory physiology by cigarette smoking in schizophrenic patients. Am J Psychiatry (1993) 2.17
Meta-analysis of 32 genome-wide linkage studies of schizophrenia. Mol Psychiatry (2008) 2.07
Acetylcholine activates an alpha-bungarotoxin-sensitive nicotinic current in rat hippocampal interneurons, but not pyramidal cells. J Neurosci (1998) 1.99
Cloning and expression of a cocaine-sensitive dopamine transporter complementary DNA. Science (1991) 1.93
Schizophrenia, sensory gating, and nicotinic receptors. Schizophr Bull (1998) 1.92
Greenhouse warming by CH4 in the atmosphere of early Earth. J Geophys Res (2000) 1.90
Genomic scan for genes predisposing to schizophrenia. Am J Med Genet (1994) 1.86
Enrichment of cis-regulatory gene expression SNPs and methylation quantitative trait loci among bipolar disorder susceptibility variants. Mol Psychiatry (2012) 1.84
Monomeric monocyte chemoattractant protein-1 (MCP-1) binds and activates the MCP-1 receptor CCR2B. J Biol Chem (1998) 1.84
Complete sequence of one of the mRNAs coding for the small subunit of ribulose bisphosphate carboxylase of Nicotiana sylvestris. Biochimie (1985) 1.77
New selective agent for isolation of Pseudomonas aeruginosa. Appl Environ Microbiol (1981) 1.75
Comparison of the regional expression of nicotinic acetylcholine receptor alpha7 mRNA and [125I]-alpha-bungarotoxin binding in human postmortem brain. J Comp Neurol (1997) 1.72
Cancer incidence in the Love Canal area. Science (1981) 1.69
Selective alpha7-nicotinic agonists normalize inhibition of auditory response in DBA mice. Psychopharmacology (Berl) (1998) 1.68
Expression of epidermal keratins and filaggrin during human fetal skin development. J Cell Biol (1985) 1.68
Deficits in sensory gating in schizophrenic patients and their relatives. Evidence obtained with auditory evoked responses. Arch Gen Psychiatry (1984) 1.63
Further linkage data on cystic fibrosis: the Utah Study. Am J Hum Genet (1986) 1.63
Smoking and mental illness. Pharmacol Biochem Behav (2001) 1.63
Autism and the serotonin transporter: the long and short of it. Mol Psychiatry (2005) 1.62
Development of a xenogeneic DNA vaccine program for canine malignant melanoma at the Animal Medical Center. Vaccine (2005) 1.59
A combined analysis of D22S278 marker alleles in affected sib-pairs: support for a susceptibility locus for schizophrenia at chromosome 22q12. Schizophrenia Collaborative Linkage Group (Chromosome 22). Am J Med Genet (1996) 1.55
Neurophysiological evidence for a defect in inhibitory pathways in schizophrenia: comparison of medicated and drug-free patients. Biol Psychiatry (1983) 1.55
Increased levels of the nicotine metabolite cotinine in schizophrenic smokers compared to other smokers. Biol Psychiatry (1997) 1.53
Normalization by nicotine of deficient auditory sensory gating in the relatives of schizophrenics. Biol Psychiatry (1992) 1.53
Primary structure of histidine-tRNA synthetase and characterization of hisS transcripts. J Biol Chem (1985) 1.53
Evidence for multiple loci from a genome scan of autism kindreds. Mol Psychiatry (2006) 1.52
The origins of the Chinese fertility decline. Demography (1990) 1.48
Neurobiological studies of sensory gating in schizophrenia. Schizophr Bull (1987) 1.44
Recombination in a schizophrenic proband fails to exclude CHRNA7 at chromosome 15q14. Mol Psychiatry (2003) 1.41
Genetic correlation of inhibitory gating of hippocampal auditory evoked response and alpha-bungarotoxin-binding nicotinic cholinergic receptors in inbred mouse strains. Neuropsychopharmacology (1996) 1.41
Identification of residues in the monocyte chemotactic protein-1 that contact the MCP-1 receptor, CCR2. Biochemistry (1999) 1.40
mu opiate receptor: cDNA cloning and expression. Proc Natl Acad Sci U S A (1993) 1.39
A second type II restriction endonuclease from Thermus aquaticus with an unusual sequence specificity. Nucleic Acids Res (1984) 1.38
[Mitral regurgitation: are we able to properly time the surgical procedure?]. Vnitr Lek (2006) 1.38
Cloning of an apparent splice variant of the rat N-methyl-D-aspartate receptor NMDAR1 with altered sensitivity to polyamines and activators of protein kinase C. Proc Natl Acad Sci U S A (1992) 1.37
Genomic organization and partial duplication of the human alpha7 neuronal nicotinic acetylcholine receptor gene (CHRNA7). Genomics (1998) 1.36
Sensory gating in schizophrenics and normal controls: effects of changing stimulation interval. Biol Psychiatry (1989) 1.36
Cholinergic gating of response to auditory stimuli in rat hippocampus. Brain Res (1992) 1.33
Temporal aspects of the electroretinogram. Arch Ophthalmol (1969) 1.32
Cloning and chromosomal mapping of three novel genes, GPR9, GPR10, and GPR14, encoding receptors related to interleukin 8, neuropeptide Y, and somatostatin receptors. Genomics (1995) 1.32
Brain pH has a significant impact on human postmortem hippocampal gene expression profiles. Brain Res (2006) 1.31
Neurophysiological and neuropsychological evidence for attentional dysfunction in schizophrenia. Schizophr Res (1993) 1.30
Effects of putative neurotransmitters on neuronal activity in monkey auditory cortex. Brain Res (1975) 1.30
Inhibitory gating of an evoked response to repeated auditory stimuli in schizophrenic and normal subjects. Human recordings, computer simulation, and an animal model. Arch Gen Psychiatry (1996) 1.28
Demographic aspects of lactation and postpartium amenorrhea. Demography (1970) 1.28
Elementary neuronal dysfunctions in schizophrenia. Schizophr Res (1991) 1.27
The record of family planning programs. Stud Fam Plann (1976) 1.26
Oncogenic transformation of murine lymphoid cells by in vitro infection with Abelson leukemia virus. J Natl Cancer Inst (1975) 1.24
Human fetal dopamine neurons grafted into the striatum in two patients with severe Parkinson's disease. A detailed account of methodology and a 6-month follow-up. Arch Neurol (1989) 1.24
Correlates of IUD termination in a mass family planning program. The first Taiwan IUD follow-up survey. Milbank Mem Fund Q (1968) 1.24
Schizophrenia and nicotinic receptors. Harv Rev Psychiatry (1998) 1.22
The activity of hippocampal interneurons and pyramidal cells during the response of the hippocampus to repeated auditory stimuli. Neuroscience (1995) 1.22
Clinicopathologic analysis of mullerian adenosarcoma: the M.D. Anderson Cancer Center experience. Oncol Rep (1998) 1.21
A high-density SNP genome-wide linkage scan in a large autism extended pedigree. Mol Psychiatry (2008) 1.20
Neuroimaging and the cognitive neuroscience of schizophrenia. Schizophr Bull (1996) 1.20
Genome-wide multipoint linkage analyses of multiplex schizophrenia pedigrees from the oceanic nation of Palau. Mol Psychiatry (2002) 1.17
Smoking and schizophrenia: abnormal nicotinic receptor expression. Eur J Pharmacol (2000) 1.17
Differential modulation of gene expression in the NMDA postsynaptic density of schizophrenic and control smokers. Brain Res Mol Brain Res (2005) 1.17
Auditory sensory gating in hippocampal neurons: a model system in the rat. Biol Psychiatry (1990) 1.16
NURR1 mutations in cases of schizophrenia and manic-depressive disorder. Am J Med Genet (2000) 1.16
Trends in fertility, family size preferences, and practice of family planning: Taiwan, 1965-1973. Stud Fam Plann (1974) 1.15
Identification of surface residues of the monocyte chemotactic protein 1 that affect signaling through the receptor CCR2. Biochemistry (1999) 1.14
Biological stability of mRNA isolated from human postmortem brain collections. Biol Psychiatry (1993) 1.14
A genome-wide search for genes predisposing to manic-depression, assuming autosomal dominant inheritance. Am J Hum Genet (1993) 1.13
Gating of auditory P50 in schizophrenics: unique effects of clozapine. Biol Psychiatry (1996) 1.13
Transplantation in Parkinson's disease: two cases of adrenal medullary grafts to the putamen. Ann Neurol (1987) 1.13
Effect of age and race on the survival of men with prostate cancer in the Metropolitan Detroit tricounty area, 1973 to 1987. Urology (1995) 1.10
Social correlates of fetal mortality. Milbank Mem Fund Q (1966) 1.10